Literature DB >> 25755600

Liver transplantation for portal cavernoma cholangiopathy.

Subash Gupta1, Sunil Taneja2.   

Abstract

Portal cavernoma cholangiopathy (PCC) is a difficult clinical problem, where the portal cavernoma is both the cause of biliary obstruction and the obstacle to its safe surgical treatment. The available endoscopic and surgical treatment is successful in majority and further intervention is seldom required since the native liver is normal. PCC is not an accepted indication for liver transplantation as only a small proportion of patients will fail both endoscopic and surgical treatment and progressive liver failure is rarely seen. Secondary biliary cirrhosis as a result of long standing biliary obstruction is an accepted indication however establishing a portal inflow in these patients is often difficult and challenging. The deceased donor liver transplantation would always be preferable over living donor liver transplantation as PCC is usually a non-emergency transplant and the graft can have portal blood inflow through a conduit to even a small segment of patent portal venous system or even to a cavernoma vessel.

Entities:  

Keywords:  DDLT, deceased donor liver transplantation; LDLT, live donor liver transplantation; PCC, portal cavernoma cholangiopathy; extrahepatic portal venous obstruction; portal biliopathy; portal hypertension; pseudosclerosing cholangitis

Year:  2014        PMID: 25755600      PMCID: PMC4244825          DOI: 10.1016/j.jceh.2014.01.001

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  13 in total

1.  Cholangiopathy in extrahepatic portal venous obstruction. Radiological appearances.

Authors:  B Nagi; R Kochhar; D Bhasin; K Singh
Journal:  Acta Radiol       Date:  2000-11       Impact factor: 1.990

Review 2.  Portal biliopathy.

Authors:  R Chandra; D Kapoor; A Tharakan; A Chaudhary; S K Sarin
Journal:  J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 4.029

3.  Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study.

Authors:  Bertrand Condat; Valérie Vilgrain; Tarik Asselah; Dermot O'Toole; Pierre Rufat; Magali Zappa; Richard Moreau; Dominique Valla
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

4.  Portal biliopathy treated by liver transplantation.

Authors:  Franco Filipponi; Lucio Urbani; Gabriele Catalano; Giuseppe Iaria; Gianni Biancofiore; Roberto Cioni; Alessandro Campatelli; Franco Mosca; Daniela Campani; Paolo Romagnoli
Journal:  Transplantation       Date:  2004-01-27       Impact factor: 4.939

Review 5.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

Review 6.  Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy.

Authors:  Vivek A Saraswat; Praveer Rai; Tarun Kumar; Samir Mohindra; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-10-22

7.  Portal biliopathy treated with living-donor liver transplant: index case.

Authors:  Subash Gupta; Ashish Singhal; Neerav Goyal; Vivek Vij; Manav Wadhawan
Journal:  Exp Clin Transplant       Date:  2011-04       Impact factor: 0.945

8.  Pseudosclerosing cholangitis in extrahepatic portal venous obstruction.

Authors:  J B Dilawari; Y K Chawla
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 9.  Live donor liver transplantation.

Authors:  Sander Florman; Charles M Miller
Journal:  Liver Transpl       Date:  2006-04       Impact factor: 5.799

10.  Adult to pediatric living donor liver transplantation for portal cavernoma.

Authors:  Mingman Zhang; Chunbao Guo; Conglun Pu; Zhimei Ren; Yingcun Li; Quan Kang; Xianqing Jin; Lvnan Yan
Journal:  Hepatol Res       Date:  2009-05-07       Impact factor: 4.288

View more
  3 in total

1.  Hepatobiliary quiz-10 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-06

Review 2.  Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Authors:  Radha K Dhiman; Vivek A Saraswat; Dominique C Valla; Yogesh Chawla; Arunanshu Behera; Vibha Varma; Swastik Agarwal; Ajay Duseja; Pankaj Puri; Naveen Kalra; Chittapuram S Rameshbabu; Vikram Bhatia; Malay Sharma; Manoj Kumar; Subhash Gupta; Sunil Taneja; Leileshwar Kaman; Showkat A Zargar; Samiran Nundy; Shivaram P Singh; Subrat K Acharya; Jang B Dilawari
Journal:  J Clin Exp Hepatol       Date:  2014-02-25

3.  Safety of supramesocolic surgery in patients with portal cavernoma without portal vein decompression. Large single centre experience.

Authors:  Safi Dokmak; Béatrice Aussilhou; Alain Sauvanet; Philippe Lévy; Aurélie Plessier; Fadhel S Ftériche; Olivier Farges; Valérie Vilgrain; Dominique C Valla; Jacques Belghiti
Journal:  HPB (Oxford)       Date:  2016-06-16       Impact factor: 3.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.